press release details

Press Releases

Lam Research Corporation Announces Financial Results for the Quarter Ended December 28, 2008

View PDF

FREMONT, Calif., Jan 28, 2009 (BUSINESS WIRE) -- Lam Research Corporation (NASDAQ:LRCX) highlights for the December 2008 quarter were:

(in thousands, except per share data and percentages)
          
 Revenue:   $283,409     
          
 Operating Margin: U.S. GAAP:  -13.2% Ongoing:  -6.1%
          
 Net Loss: U.S. GAAP: $(24,172) Ongoing: $(11,748)
          
 Diluted EPS: U.S. GAAP: $(0.19) Ongoing: $(0.09)
 

Lam Research Corporation today announced financial results for the quarter ended December 28, 2008. Revenue for the period was $283.4 million, gross margin was $101.4 million and net loss was $(24.2) million, or $(0.19) per diluted share, compared to revenue of $440.4 million, gross margin of $183.1 million and net income of $8.9 million, or $0.07 per diluted share, for the September 2008 quarter. Shipments for the December 2008 quarter were $226 million compared to $345 million during the September 2008 quarter.

The Company's ongoing results for the December 2008 quarter exclude certain costs for restructuring activities and asset impairments designed to better align the Company's cost structure with its business opportunities in consideration of market and economic uncertainties, a net tax benefit related to the renewal of the research and development tax credit, net tax expense on resolution of certain tax items, one-time costs associated with the restructuring of an employee benefit plan, exchange rate loss associated with the Company's accelerated tax planning strategy, and interest on the tax liability associated with the outcome of the Company's previously disclosed voluntary internal stock option review. The Company's September 2008 quarter excluded certain costs for restructuring activities and asset impairments related to the integration of SEZ, net tax expense on accelerated tax planning strategy, and interest on the tax liability associated with the outcome of the Company's previously disclosed voluntary internal stock option review. Management uses the presentation of ongoing gross margin, ongoing operating income, ongoing net income, and ongoing diluted earnings per share to evaluate the Company's operating and financial results. The Company believes the presentation of ongoing results is useful to investors for analyzing ongoing business trends and comparing performance to prior periods, and enhances the investor's ability to view the Company's results from management's perspective. A table presenting a reconciliation of ongoing results to results under U.S. GAAP is included at the end of this press release and on the Company's web site.

Ongoing net loss was $(11.7) million, or $(0.09) per diluted share in the December 2008 quarter compared to ongoing net income of $32.6 million, or $0.26 per diluted share, for the September 2008 quarter. Ongoing gross margin for the December 2008 quarter was $109.1 million or 38.5%, compared to ongoing gross margin of $186.2 million, or 42.3%, for the September 2008 quarter. The sequential decline in gross margin was primarily due to reduced manufacturing and field utilization levels and product mix challenges resulting from the reduced business activity. Ongoing operating expenses for the December 2008 quarter decreased to $126.5 million compared with the September 2008 quarter of $149.9 million. This decrease was driven by a reduction in employee variable compensation expenses, a reduction in deferred compensation liabilities due to recent stock market declines, and the partial quarter impact of the Company's December quarter restructuring activities.

The geographic distribution of shipments and revenue during the December 2008 quarter is shown in the following table:

Region Shipments Revenue
North America 17% 15%
Europe 12% 10%
Japan 22% 28%
Korea 17% 22%
Asia Pacific 32% 25%
 

Cash and cash equivalents, short-term investments and restricted cash and investments balances were $1.1 billion at the end of the December 2008 quarter, compared to $1.2 billion at the end of the September 2008 quarter. Cash flows from operating activities were approximately $(39.0) million during the December quarter. Deferred revenue and deferred profit balances at the end of the December 2008 quarter were $68.4 million and $54.2 million, respectively. At the end of the December 2008 quarter, the anticipated future revenue value of orders shipped to Japanese customers that was not recorded as deferred revenue was approximately $8.6 million.

"The global semiconductor industry has entered one of the most difficult periods in its history, one that is presenting severe challenges to our customers and thus severely limiting investment in wafer fab equipment," said Steve Newberry, Lam's president and chief executive officer. "While this environment will persist near-term, we remain optimistic about our long-term technology roadmap in etch, clean and other new markets. During the pause in customer spending we are strategically targeting our capital resources to new penetration opportunities, qualifying our next-generation tools and delivering cost-effective technology solutions aimed at reducing our customers' production costs. Our objective through these actions is to deliver superior value to our customers and emerge from this period of reduced spending well positioned to deliver strong financial and operational performance," Newberry concluded.

Statements made in this press release which are not statements of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate, but are not limited, to our ability to align our cost structure with our business opportunities, our future plans, areas of focus, and technology roadmap, our expectations for our ability to deliver long term strong financial and operational performance, our belief that our efforts will help us emerge from the current environment in a strong position to enable future revenue and profit growth, and our ability to succeed in delivering cost effective technology solutions to our customers. Some factors that may affect these forward-looking statements include: difficult business conditions in the semiconductor industry and the overall economy and the efficacy of our plans for reacting to those conditions, factors that tend to make our quarterly results more volatile (such as exchange rate fluctuations), changing customer demands, and the challenges presented by our new products and the integration of acquired businesses and technologies into our existing business. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed with the Securities and Exchange Commission, including specifically the report on Form 10-K for the year ended June 29, 2008, and Form 10-Q for the quarter ended September 28, 2008, which could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world's semiconductor industry. Lam's common stock trades on The NASDAQ Global Select Market SM under the symbol LRCX. Lam is a NASDAQ-100 ® company. For more information, visit www.lamresearch.com.

LAM RESEARCH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited)
           
  Three Months Ended Six Months Ended
  December 28, September 28, December 23, December 28, December 23,
   2008   2008   2007   2008   2007 
Total revenue $283,409  $440,361  $610,320  $723,770  $1,294,941 
Cost of goods sold  174,329   254,203   302,659   428,532   643,393 
Cost of goods sold - restructuring and asset impairments  7,728   3,048   -   10,776   - 
Total cost of goods sold  182,057   257,251   302,659   439,308   643,393 
Gross margin  101,352   183,110   307,661   284,462   651,548 
Gross margin as a percent of revenue  35.8%  41.6%  50.4%  39.3%  50.3%
Research and development  68,781   81,563   80,243   150,344   156,531 
Selling, general and administrative  59,842   69,060   66,084   128,902   135,797 
Restructuring and asset impairments  10,121   15,968   -   26,089   - 
Total operating expenses  138,744   166,591   146,327   305,335   292,328 
Operating income (loss)  (37,392)  16,519   161,334   (20,873)  359,220 
Operating margin as a percent of revenue  -13.2%  3.8%  26.4%  -2.9%  27.7%
Other income (expense), net  (7,233)  9,017   (37)  1,784   7,596 
Income (loss) before income taxes  (44,625)  25,536   161,297   (19,089)  366,816 
Income tax expense (benefit)  (20,453)  16,663   46,238   (3,790)  103,169 
Net income (loss) $(24,172) $8,873  $115,059  $(15,299) $263,647 
Net income (loss) per share:          
Basic net income (loss) per share $(0.19) $0.07  $0.92  $(0.12) $2.12 
Diluted net income (loss) per share $(0.19) $0.07  $0.91  $(0.12) $2.08 
Number of shares used in per share calculations:          
Basic  125,084   125,527   124,685   125,266   124,370 
Diluted  125,084   126,819   126,653   125,266   126,523 
 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
       
  December 28, September 28, June 29,
   2008  2008  2008
  (unaudited) (unaudited)  

(1)

ASSETS      
Cash and cash equivalents $652,913 $745,432 $732,537
Short-term investments  297,399  313,803  326,199
Accounts receivable, net  290,565  311,633  412,356
Inventories  269,959  272,215  282,218
Deferred income taxes  93,002  95,186  96,748
Other current assets  56,648  69,983  67,649
Total current assets  1,660,486  1,808,252  1,917,707
Property and equipment, net  233,250  230,377  235,735
Restricted cash and investments  168,405  156,148  146,072
Deferred income taxes  25,836  33,762  19,793
Goodwill and intangible assets  371,987  374,538  403,187
Other assets  78,457  81,493  84,261
Total assets $2,538,421 $2,684,570 $2,806,755
       
LIABILITIES AND STOCKHOLDERS' EQUITY      
Current liabilities $446,412 $533,722 $637,679
       
Long-term debt and capital leases $257,135 $269,256 $276,121
Income taxes payable  92,382  94,184  85,611
Other long-term liabilities  21,300  21,875  23,400
Minority interests  -  4,789  5,347
Stockholders' equity  1,721,192  1,760,744  1,778,597
Total liabilities and stockholders' equity $2,538,421 $2,684,570 $2,806,755
       
1 Derived from audited financial statements      
 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
           
  Three Months Ended Six Months Ended
  December 28, September 28, December 23, December 28, December 23,
   2008   2008   2007   2008   2007 
           
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss) $(24,172) $8,873  $115,059  $(15,299) $263,647 
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:          
          
Depreciation and amortization  17,177   17,896   11,324   35,073   22,563 
Deferred income taxes  10,110   (12,407)  776   (2,297)  (10,014)
Equity-based compensation expense  14,049   15,408   9,813   29,457   20,615 
Income tax benefit on equity-based compensation plans  (7,045)  5,039   21,277   (2,006)  57,177 
Excess tax benefit on equity-based compensation plans  3,752   (4,269)  (16,488)  (517)  (37,639)
Restructuring and asset impairments  17,849   19,016   -   36,865   - 
Other, net  3,200   2,665   9,939   5,865   11,316 
Changes in operating asset accounts  (73,909)  (9,089)  (130,260)  (82,998)  (83,778)
Net cash provided by (used for) operating activities  (38,989)  43,132   21,440   4,143   243,887 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Capital expenditures and intangible assets  (12,417)  (15,151)  (24,417)  (27,568)  (38,561)
Acquisitions of businesses, net of cash acquired  (8,763)  (2,427)  -   (11,190)  - 
Net sales (purchases) of available-for-sale securities  39,767   6,980   (15,900)  46,747   (31,885)
Purchase of call option  -   -   (10,279)  -   (10,279)
Purchases of other investments  -   -   (4,560)  -   (4,560)
Other  (2,000)  -   (2,248)  (2,000)  (2,248)
Transfer of restricted cash and investments  (32,178)  (16,128)  (1,074)  (48,306)  (1,074)
Net cash used for investing activities  (15,591)  (26,726)  (58,478)  (42,317)  (88,607)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Principal payments on long-term debt and capital lease obligations  (13,060)  (2,390)  (51)  (15,450)  (100)
Net proceeds from issuance of long-term debt  515   127   -   642   - 
Excess tax benefit on equity-based compensation plans  (3,752)  4,269   16,488   517   37,639 
Treasury stock purchases  (24,448)  (2,755)  (761)  (27,203)  (10,225)
Reissuances of treasury stock  -   7,584   -   7,584   7,301 
Proceeds from issuance of common stock  1,294   3,150   3,398   4,444   10,106 
Net cash provided by (used for) financing activities  (39,451)  9,985   19,074   (29,466)  44,721 
Effect of exchange rate changes on cash  1,512   (13,496)  851   (11,984)  2,087 
Net increase (decrease) in cash and cash equivalents  (92,519)  12,895   (17,113)  (79,624)  202,088 
Cash and cash equivalents at beginning of period  745,432   732,537   793,168   732,537   573,967 
Cash and cash equivalents at end of period $652,913  $745,432  $776,055  $652,913  $776,055 
 
Reconciliation of U.S. GAAP Net Income (Loss) to Ongoing Net Income (Loss)
(in thousands, except per share data and percentages)
     
  Three Months Ended Three Months Ended
  December 28, September 28,
   2008   2008 
U.S. GAAP net income (loss) $(24,172) $8,873 
Pre-tax non-ongoing items:    
Restructuring and asset impairments - cost of goods sold  7,728   3,048 
Restructuring and asset impairments - operating expenses  10,121   15,968 
Restructuring of employee benefit plan - operating expenses  1,300   - 
Voluntary internal stock option review - operating expenses  843   761 
Exchange rate loss associated with accelerated tax planning strategy - other income (expense), net  7,569   - 
Net tax benefit on non-ongoing items  (7,375)  (5,325)
Net tax benefit on renewal of r&d tax credit  (5,751)  - 
Net tax expense on resolution of certain tax matters  1,396   - 
Net tax expense (benefit) on accelerated tax planning strategy  (3,407)  9,310 
Ongoing net income (loss) $(11,748) $32,635 
Ongoing net income (loss) per diluted share $(0.09) $0.26 
Number of shares used for diluted per share calculation  125,084   126,819 
U.S. GAAP income tax rate  45.8%  65.3%
Ongoing income tax rate  31.2%  28.0%
     
     
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income (Loss) to Ongoing Gross Margin, Operating Expenses and Operating Income (Loss)
(in thousands, except percentages)
     
  Three Months Ended Three Months Ended
  December 28, September 28,
   2008   2008 
U.S. GAAP gross margin $101,352  $183,110 
Pre-tax non-ongoing items:    
Restructuring and asset impairments - cost of goods sold  7,728   3,048 
Ongoing gross margin $109,080  $186,158 
U.S. GAAP gross margin as a percent of revenue  35.8%  41.6%
Ongoing gross margin as a percent of revenue  38.5%  42.3%
U.S. GAAP operating expenses $138,744  $166,591 
Pre-tax non-ongoing items:    
Restructuring and asset impairments - operating expenses  (10,121)  (15,968)
Restructuring of employee benefit plan - operating expenses  (1,300)  - 
Voluntary internal stock option review - operating expenses  (843)  (761)
Ongoing operating expenses $126,480  $149,862 
Ongoing operating income (loss) $(17,400) $36,296 
Ongoing operating income (loss) as a percent of revenue  -6.1%  8.2%
 

 

SOURCE: Lam Research Corporation

Lam Research Corporation
Carol Raeburn, 510-572-4450 (Investor Relations)
Senior Director
carol.raeburn@lamresearch.com

Copyright Business Wire 2009